3De Groen PC, Gores GJ, LaRusso NF, et al. Biliary tract cancers. N Engl J Med, 1999, 341: 1368-1378.
4Bjomsson E, Kilander A, Oisson R. CA19-9 and CEA are unreliable markers for cholangiocarcinoma in patients with primary sclerosing cholangitis. Liver, 1999, 19: 501-508.
5Patel AH, Harnois DM, Klee GG, et al. The utility of CA19-9 in the diagnosis of cholangiocarcinoma in patients without primary sclerosing cholangitis. Am J Gastroenterol, 2000, 95: 204-207.
2Departments of Surgical Oncology (Wu FS, Zhao WH, Ma ZM, Teng LS and Wang M) and General Surgery ( Liang TB and Zheng SS) , First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.Survival factors after resection of small hepatocellular carcinoma[J].Hepatobiliary & Pancreatic Diseases International,2005,4(3):379-384. 被引量:5